Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immuneering (IMRX)
NASDAQ:IMRX
Immuneering (IMRX) Financial Statements
113 Followers
Immuneering Financial Overview
| Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 19.20K | - | - | - | $ 39.57K |
| Gross Profit | $ 19.20K | - | - | - | $ 39.57K |
| EBIT | $ -14.31M | $ -16.30M | $ -12.60M | $ -12.19M | $ -14.44M |
| EBITDA | $ -14.28M | $ -16.21M | - | $ -12.00M | $ -14.43M |
| Net Income Common Stockholders | $ -14.31M | $ -15.08M | $ -12.60M | $ -12.19M | $ -13.60M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 71.28M | $ 85.67M | $ 97.24M | $ 108.99M | $ 91.54M |
| Total Assets | $ 87.98M | $ 102.58M | $ 113.88M | $ 124.90M | $ 107.70M |
| Total Debt | $ 4.38M | $ 4.46M | $ 4.54M | $ 4.64M | $ 4.74M |
| Net Debt | $ -66.90M | $ -81.20M | $ -92.70M | $ -104.34M | $ -86.79M |
| Total Liabilities | $ 9.26M | $ 12.01M | $ 9.86M | $ 9.79M | $ 9.91M |
| Stockholders Equity | $ 78.72M | $ 90.58M | $ 104.02M | $ 115.10M | $ 97.79M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -15.53M | $ -11.95M | - | $ -10.84M | $ -14.45M |
| Operating Cash Flow | $ -15.49M | $ -11.78M | $ -12.03M | $ -10.75M | $ -14.42M |
| Investing Cash Flow | $ 21.39M | $ 3.13M | $ -23.97M | $ 9.16M | $ 18.97M |
| Financing Cash Flow | $ 979.92K | $ 7.83K | $ 21.45K | $ 28.17M | $ 239.41K |